A detailed history of Bank Of Montreal transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 11,996 shares of CTKB stock, worth $78,573. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,996
Previous 10,296 16.51%
Holding current value
$78,573
Previous $57,000 15.79%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$4.73 - $6.73 $8,041 - $11,441
1,700 Added 16.51%
11,996 $66,000
Q2 2024

Aug 14, 2024

BUY
$5.3 - $6.91 $614 - $801
116 Added 1.14%
10,296 $57,000
Q1 2024

May 13, 2024

BUY
$6.29 - $9.15 $220 - $320
35 Added 0.34%
10,180 $68,000
Q4 2023

Feb 08, 2024

BUY
$4.1 - $9.51 $41,594 - $96,478
10,145 New
10,145 $92,000
Q1 2023

Jun 13, 2024

BUY
$8.44 - $13.47 $3,755 - $5,994
445 Added 4.37%
10,625 $97,000
Q4 2022

Feb 01, 2023

BUY
$9.71 - $15.86 $109,625 - $179,059
11,290 New
11,290 $115,000

Others Institutions Holding CTKB

About Cytek Biosciences, Inc.


  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $882M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.